메뉴 건너뛰기




Volumn 117, Issue 5-6, 2007, Pages 213-220

Assessment of plasminogen activator inhibitor-1 and von Willebrand factor as a marers of endothelial function in patients with end-stage kidney disease after allotransplantation during a one-year follow-up;Ocena stȩżenia inhibitora aktywatora plazminogenu typu 1 i czynnika von Willebranda jako markerów czynności śródbłonka u pacjentów w okresie schyłkowej niewydolności nerek po allotransplantacji w obserwacji rocznej

Author keywords

Chronic kidney disease; Endothelium; Kidney allotransplantation

Indexed keywords

CREATININE; HOMOCYSTEINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

EID: 34848849825     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.134     Document Type: Article
Times cited : (3)

References (32)
  • 1
    • 0036741488 scopus 로고    scopus 로고
    • Statins and renal function
    • Elisaf M, Mikhailidis DP. Statins and renal function. Angiology. 2002; 53: 493-502.
    • (2002) Angiology , vol.53 , pp. 493-502
    • Elisaf, M.1    Mikhailidis, D.P.2
  • 2
    • 0034649302 scopus 로고    scopus 로고
    • Mental stress induces transient endothelial dysfunction in humans
    • Ghiadoni L, Donald A, Cropley M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation. 2000; 14: 2473-2478.
    • (2000) Circulation , vol.14 , pp. 2473-2478
    • Ghiadoni, L.1    Donald, A.2    Cropley, M.3
  • 3
    • 0034791021 scopus 로고    scopus 로고
    • Endothelial dysfunction and inflamation - is there a link?
    • Stenvinkel P. Endothelial dysfunction and inflamation - is there a link? Nephrol Dial Transplant. 2001; 16: 1968-71.
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 1968-1971
    • Stenvinkel, P.1
  • 4
    • 0033755958 scopus 로고    scopus 로고
    • Endothelial cell activation injury, damage and dysfunction: Separate entities or mutual terms?
    • Blann AD. Endothelial cell activation injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis. 2000; 7: 623-630.
    • (2000) Blood Coagul Fibrinolysis , vol.7 , pp. 623-630
    • Blann, A.D.1
  • 5
    • 0037406338 scopus 로고    scopus 로고
    • Endothelial dysfunction and inflammation: What is the link?
    • Galle J, Quasching T, Seibold S, et al. Endothelial dysfunction and inflammation: what is the link? Kidney Int. 2003; 63 (Suppl 84): S45-S49.
    • (2003) Kidney Int , vol.63 , Issue.SUPPL. 84
    • Galle, J.1    Quasching, T.2    Seibold, S.3
  • 6
    • 0036362469 scopus 로고    scopus 로고
    • Fibrinolysis in chronic renal failure, dialysis and renal transplantation
    • Opatmy K, Zemanova P, Opartna S, et al. Fibrinolysis in chronic renal failure, dialysis and renal transplantation. Ann Transplant. 2002; 7: 34-35.
    • (2002) Ann Transplant , vol.7 , pp. 34-35
    • Opatmy, K.1    Zemanova, P.2    Opartna, S.3
  • 7
    • 0032127738 scopus 로고    scopus 로고
    • Regulation of local tissue type plasminogen activator release by endothelium independent agonists in human vasculatione
    • Stein CM. Regulation of local tissue type plasminogen activator release by endothelium independent agonists in human vasculatione. J Am Coll Cardiol. 1998; 32: 117-122.
    • (1998) J Am Coll Cardiol , vol.32 , pp. 117-122
    • Stein, C.M.1
  • 8
    • 0034808298 scopus 로고    scopus 로고
    • Clinically important factors influencing endothelial function
    • Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit. 2001; 7: 1075-1085.
    • (2001) Med Sci Monit , vol.7 , pp. 1075-1085
    • Vapaatalo, H.1    Mervaala, E.2
  • 9
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am Kidney Dis. 2002; 39: S1-S266.
    • (2002) Am Kidney Dis , vol.39
  • 10
    • 0242441465 scopus 로고    scopus 로고
    • Kidney disease as a risk factor for development of cardiovascular disease a Statement From the American Heart Association Councils of Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42: 1050-1065
    • Kidney disease as a risk factor for development of cardiovascular disease a Statement From the American Heart Association Councils of Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42: 1050-1065.
  • 11
    • 16644393405 scopus 로고    scopus 로고
    • Cardiovascular risk in chronic kidney disease
    • Anavekar NS, Pfeffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int. 2004; S92: 11-15.
    • (2004) Kidney Int , vol.S92 , pp. 11-15
    • Anavekar, N.S.1    Pfeffer, M.A.2
  • 12
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1308.
    • (2004) N Engl J Med , vol.351 , pp. 1296-1308
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3
  • 13
    • 0035997866 scopus 로고    scopus 로고
    • Cardiorenal risk: An important clinical intersection
    • McCullough PA. Cardiorenal risk: an important clinical intersection. Rev In Cardiovasc Med. 2002; 2: 71-76.
    • (2002) Rev In Cardiovasc Med , vol.2 , pp. 71-76
    • McCullough, P.A.1
  • 14
    • 0036406195 scopus 로고    scopus 로고
    • Risk factors for late kidney allograft failure
    • Ponticelli C, Villa M, Cesana B, et al. Risk factors for late kidney allograft failure. Kidney Int. 2002; 62: 1848-1854.
    • (2002) Kidney Int , vol.62 , pp. 1848-1854
    • Ponticelli, C.1    Villa, M.2    Cesana, B.3
  • 15
    • 34848843855 scopus 로고    scopus 로고
    • Transplantologia kliniczna
    • Rowiński W, Wałaszewski J, Pa̧czek L, eds
    • Rowiński W, Wałaszewski J, Pa̧czek L, eds. Transplantologia kliniczna. Warszawa, WL PZWL, 2004.
    • (2004) Warszawa, WL PZWL
  • 16
    • 0032244657 scopus 로고    scopus 로고
    • The effect of cyclosporine on regulators of fibrinolysis in plasma allograft recipients
    • Elhasade AS, Perkowska A, Pa̧czek L, et al. The effect of cyclosporine on regulators of fibrinolysis in plasma allograft recipients. Ann Transplant. 1998; 3: 13-18.
    • (1998) Ann Transplant , vol.3 , pp. 13-18
    • Elhasade, A.S.1    Perkowska, A.2    Pa̧czek, L.3
  • 17
    • 0029769508 scopus 로고    scopus 로고
    • The coagulolytic system and endothelial function in cyclosporine kidney allograft recipients
    • Małyszko J, Małyszko JS, Pawlak K, et al. The coagulolytic system and endothelial function in cyclosporine kidney allograft recipients. Transplantation. 1996; 62: 828-830.
    • (1996) Transplantation , vol.62 , pp. 828-830
    • Małyszko, J.1    Małyszko, J.S.2    Pawlak, K.3
  • 18
    • 0036264147 scopus 로고    scopus 로고
    • Regulation of fibrinolysis in plasma of kidney transplant recipients
    • Perkowska A, Elhasade A, Gaciong Z, et al. Regulation of fibrinolysis in plasma of kidney transplant recipients. Transplant Proc. 2002; 34: 585-588.
    • (2002) Transplant Proc , vol.34 , pp. 585-588
    • Perkowska, A.1    Elhasade, A.2    Gaciong, Z.3
  • 19
    • 0035077680 scopus 로고    scopus 로고
    • An association between fibrinolytic activity and graft function in transplantation recipients
    • Perkowska A, Elhasade AS, Gaciong Z, et al. An association between fibrinolytic activity and graft function in transplantation recipients. Transplant Proc. 2001; 33: 409-411.
    • (2001) Transplant Proc , vol.33 , pp. 409-411
    • Perkowska, A.1    Elhasade, A.S.2    Gaciong, Z.3
  • 20
    • 0027371513 scopus 로고
    • Willebrand factor and the endothelium in vascular disease
    • Blann AD. Von Willebrand factor and the endothelium in vascular disease. Br J Biochem Sci. 1993; 50: 125-134.
    • (1993) Br J Biochem Sci , vol.50 , pp. 125-134
    • Von, B.A.D.1
  • 21
    • 0030621567 scopus 로고    scopus 로고
    • Tkankowy aktywator plazminogenu tPA Ag i inhibitor aktywatora plazminogenu PAI-1 w czasie hemodializy u chorych z przewlekła̧ niewydolnościa̧ nerek
    • Pia̧tkowska M, Kotschy M, Nartowicz E, et al. Tkankowy aktywator plazminogenu tPA Ag i inhibitor aktywatora plazminogenu PAI-1 w czasie hemodializy u chorych z przewlekła̧ niewydolnościa̧ nerek. Pol Merk Lek. 1997; 2: 205-207.
    • (1997) Pol Merk Lek , vol.2 , pp. 205-207
    • Pia̧tkowska, M.1    Kotschy, M.2    Nartowicz, E.3
  • 22
    • 3943110721 scopus 로고    scopus 로고
    • Układ fibrynolizy krwi chorych na przewlekła̧ niewydolność nerek poddawanych hemodializie
    • Rość D, Bronisz M, Zastawna E, et al. Układ fibrynolizy krwi chorych na przewlekła̧ niewydolność nerek poddawanych hemodializie. Nefrol Dial Pol. 2000; 4: 156-160.
    • (2000) Nefrol Dial Pol , vol.4 , pp. 156-160
    • Rość, D.1    Bronisz, M.2    Zastawna, E.3
  • 23
    • 0029021840 scopus 로고
    • Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment
    • Patrasi GM, Santori MT, Rigotti P, et al. Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment. Transplantation. 1995; 59: 1416-1420.
    • (1995) Transplantation , vol.59 , pp. 1416-1420
    • Patrasi, G.M.1    Santori, M.T.2    Rigotti, P.3
  • 24
    • 0345593810 scopus 로고    scopus 로고
    • Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients
    • van den Dorpel MA, Veld AJ, Levi M, et al. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. Arterioscler Thromb Vasc Biol. 1999; 19: 1555-1558.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 1555-1558
    • van den Dorpel, M.A.1    Veld, A.J.2    Levi, M.3
  • 25
    • 0035960331 scopus 로고    scopus 로고
    • Vascular endothelial function in cyclosporine and tacrolimus treatment transplant recipients
    • Ovuworie CA, Fox ER, Chow P, et al. Vascular endothelial function in cyclosporine and tacrolimus treatment transplant recipients. Transplantation. 2001; 72: 1385-1388.
    • (2001) Transplantation , vol.72 , pp. 1385-1388
    • Ovuworie, C.A.1    Fox, E.R.2    Chow, P.3
  • 26
    • 0035143389 scopus 로고    scopus 로고
    • Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus
    • Ligtenberg G, Hene RJ, Blankestijn PJ, et al. Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol. 2001; 12: 368-373.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 368-373
    • Ligtenberg, G.1    Hene, R.J.2    Blankestijn, P.J.3
  • 27
    • 0027232337 scopus 로고
    • Expression and localization of plasminogen activator inhibitor 1 mRNA in transplant kidneys
    • Wang Y, Thompson EM, Whawell SA, et al. Expression and localization of plasminogen activator inhibitor 1 mRNA in transplant kidneys. J Pathology. 1993; 169: 445-450.
    • (1993) J Pathology , vol.169 , pp. 445-450
    • Wang, Y.1    Thompson, E.M.2    Whawell, S.A.3
  • 28
    • 0028034116 scopus 로고
    • Natural anticoagulant and fibrinolytic pathways in renal allograft failure
    • Torry RJ, Labamerre CA, Gargirlo P, et al. Natural anticoagulant and fibrinolytic pathways in renal allograft failure. Transplantation. 1994; 58: 926-931.
    • (1994) Transplantation , vol.58 , pp. 926-931
    • Torry, R.J.1    Labamerre, C.A.2    Gargirlo, P.3
  • 29
    • 0029122148 scopus 로고
    • Von Willebrand factor, a possible indicator of endothelial damage, decreases during long-term compliance with a lipid-lowering diet
    • Blann AD, Jackson P, Bath PMW, et al. Von Willebrand factor, a possible indicator of endothelial damage, decreases during long-term compliance with a lipid-lowering diet. J Intern Med. 1995; 237: 557-561.
    • (1995) J Intern Med , vol.237 , pp. 557-561
    • Blann, A.D.1    Jackson, P.2    Bath, P.M.W.3
  • 30
    • 0026333959 scopus 로고
    • Role of oxidized low density lipoprotein in atherogenesis
    • Witztum RJ, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991; 88: 1785-1792.
    • (1991) J Clin Invest , vol.88 , pp. 1785-1792
    • Witztum, R.J.1    Steinberg, D.2
  • 31
    • 0027250120 scopus 로고
    • Markers of endothelial perturbation and damage
    • Pearson JD. Markers of endothelial perturbation and damage. Br J Rheumatol. 1993; 32: 651-652.
    • (1993) Br J Rheumatol , vol.32 , pp. 651-652
    • Pearson, J.D.1
  • 32
    • 0027948481 scopus 로고
    • Vessel wall interactions regulating thrombosis
    • Pearson JD. Vessel wall interactions regulating thrombosis. Br Med Bull. 1994; 50: 776-788.
    • (1994) Br Med Bull , vol.50 , pp. 776-788
    • Pearson, J.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.